Literature DB >> 22271313

Dormant but migratory tumour cells in desmoplastic stroma of invasive ductal carcinomas.

Vanisri Raviraj1, Hui Zhang, Hsin-ya Chien, Louise Cole, Erik W Thompson, Lilian Soon.   

Abstract

Mortality in breast cancer is linked to metastasis and recurrence yet there is no acceptable biological model for cancer relapse. We hypothesise that there might exist primary tumour cells capable of escaping surgery by migration and resisting radiotherapy and chemotherapy to cause cancer recurrence. We investigated this possibility in invasive ductal carcinoma (IDC) tissue and observed the presence of solitary primary tumour cells (SPCs) in the dense collagen stroma that encapsulates intratumoural cells (ICs). In IDC tissue sections, collagen was detected with either Masson's Trichrome or by second harmonics imaging. Cytokeratin-19 (CK-19) and vimentin (VIM) antibodies were, respectively, used to identify epithelial-derived tumour cells and to indicate epithelial to mesenchymal transition (EMT). Confocal/multiphoton microscopy showed that ICs from acini were mainly CK-19(+ve) and were encapsulated by dense stromal collagen. Within the stroma, SPCs were detected by their staining for both CK-19 and VIM (confirming EMT). ICs and SPCs were subsequently isolated by laser capture microdissection followed by multiplex tandem-PCR studies. SPCs were found to be enriched for pro-migratory and anti-proliferative genes relative to ICs. In vitro experiments using collagen matrices at 20 mg/cm(3), similar in density to tumour matrices, demonstrated that SPC-like cells were highly migratory but dormant, phenotypes that recapitulated the genotypes of SPCs in clinical tissue. These data suggest that SPCs located at the breast cancer perimeter are invasive and dormant such that they may exceed surgical margins and resist local and adjuvant therapies. This study has important connotations for a role of SPCs in local recurrence.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22271313     DOI: 10.1007/s10585-011-9450-4

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  93 in total

Review 1.  Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways.

Authors:  Lionel Larue; Alfonso Bellacosa
Journal:  Oncogene       Date:  2005-11-14       Impact factor: 9.867

2.  Cell proliferation, apoptosis, and expression of cyclin D1 and cyclin E as potential biomarkers in tamoxifen-treated mammary tumors.

Authors:  Konstantin Christov; Amy Ikui; Anne Shilkaitis; Albert Green; Ruisheng Yao; Ming You; Clinton Grubbs; Vernon Steele; Ronald Lubet; I Bernard Weinstein
Journal:  Breast Cancer Res Treat       Date:  2003-02       Impact factor: 4.872

3.  Tumour vascularity and basement membrane structure in breast cancer as related to tumour histology and prognosis.

Authors:  P Lipponen; H Ji; S Aaltomaa; K Syrjänen
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

4.  Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction.

Authors:  Y H Datta; P T Adams; W R Drobyski; S P Ethier; V H Terry; M S Roth
Journal:  J Clin Oncol       Date:  1994-03       Impact factor: 44.544

5.  Systemic spread is an early step in breast cancer.

Authors:  Yves Hüsemann; Jochen B Geigl; Falk Schubert; Piero Musiani; Manfred Meyer; Elke Burghart; Guido Forni; Roland Eils; Tanja Fehm; Gert Riethmüller; Christoph A Klein
Journal:  Cancer Cell       Date:  2008-01       Impact factor: 31.743

6.  Downregulation of connective tissue growth factor by three-dimensional matrix enhances ovarian carcinoma cell invasion.

Authors:  Maria V Barbolina; Brian P Adley; David L Kelly; Jaclyn Shepard; Angela J Fought; Denise Scholtens; Peter Penzes; Lonnie D Shea; M Sharon Stack
Journal:  Int J Cancer       Date:  2009-08-15       Impact factor: 7.396

7.  Enhanced expression of vimentin in motile prostate cell lines and in poorly differentiated and metastatic prostate carcinoma.

Authors:  Shona H Lang; Catherine Hyde; Ian N Reid; Ian S Hitchcock; Claire A Hart; A A Gordon Bryden; Jean-Marie Villette; Michael J Stower; Norman J Maitland
Journal:  Prostate       Date:  2002-09-01       Impact factor: 4.104

8.  Visualizing spatiotemporal dynamics of multicellular cell-cycle progression.

Authors:  Asako Sakaue-Sawano; Hiroshi Kurokawa; Toshifumi Morimura; Aki Hanyu; Hiroshi Hama; Hatsuki Osawa; Saori Kashiwagi; Kiyoko Fukami; Takaki Miyata; Hiroyuki Miyoshi; Takeshi Imamura; Masaharu Ogawa; Hisao Masai; Atsushi Miyawaki
Journal:  Cell       Date:  2008-02-08       Impact factor: 41.582

9.  Multiplexed tandem PCR: gene profiling from small amounts of RNA using SYBR Green detection.

Authors:  Keith K Stanley; Elektra Szewczuk
Journal:  Nucleic Acids Res       Date:  2005-11-24       Impact factor: 16.971

10.  Mechanism of N-WASP activation by CDC42 and phosphatidylinositol 4, 5-bisphosphate.

Authors:  R Rohatgi; H Y Ho; M W Kirschner
Journal:  J Cell Biol       Date:  2000-09-18       Impact factor: 10.539

View more
  14 in total

1.  Combined SFK/MEK inhibition prevents metastatic outgrowth of dormant tumor cells.

Authors:  Lara H El Touny; Anthony Vieira; Arnulfo Mendoza; Chand Khanna; Mark J Hoenerhoff; Jeffrey E Green
Journal:  J Clin Invest       Date:  2013-12-09       Impact factor: 14.808

Review 2.  A review of the influence of mammographic density on breast cancer clinical and pathological phenotype.

Authors:  Michael S Shawky; Cecilia W Huo; Kara Britt; Erik W Thompson; Michael A Henderson; Andrew Redfern
Journal:  Breast Cancer Res Treat       Date:  2019-06-08       Impact factor: 4.872

3.  Functional analysis of single cells identifies a rare subset of circulating tumor cells with malignant traits.

Authors:  Xiaosai Yao; Atish D Choudhury; Yvonne J Yamanaka; Viktor A Adalsteinsson; Todd M Gierahn; Christina A Williamson; Carla R Lamb; Mary-Ellen Taplin; Mari Nakabayashi; Matthew S Chabot; Tiantian Li; Gwo-Shu M Lee; Jesse S Boehm; Philip W Kantoff; William C Hahn; K Dane Wittrup; J Christopher Love
Journal:  Integr Biol (Camb)       Date:  2014-02-13       Impact factor: 2.192

Review 4.  Molecular characterization of basal-like and non-basal-like triple-negative breast cancer.

Authors:  Aleix Prat; Barbara Adamo; Maggie C U Cheang; Carey K Anders; Lisa A Carey; Charles M Perou
Journal:  Oncologist       Date:  2013-02-12

5.  High mammographic density is associated with an increase in stromal collagen and immune cells within the mammary epithelium.

Authors:  Cecilia W Huo; Grace Chew; Prue Hill; Dexing Huang; Wendy Ingman; Leigh Hodson; Kristy A Brown; Astrid Magenau; Amr H Allam; Ewan McGhee; Paul Timpson; Michael A Henderson; Erik W Thompson; Kara Britt
Journal:  Breast Cancer Res       Date:  2015-06-04       Impact factor: 6.466

6.  Preferential, enhanced breast cancer cell migration on biomimetic electrospun nanofiber 'cell highways'.

Authors:  Mark Tyler Nelson; Aaron Short; Sara L Cole; Amy C Gross; Jessica Winter; Tim D Eubank; John J Lannutti
Journal:  BMC Cancer       Date:  2014-11-10       Impact factor: 4.430

Review 7.  Controversies around epithelial-mesenchymal plasticity in cancer metastasis.

Authors:  Elizabeth D Williams; Dingcheng Gao; Andrew Redfern; Erik W Thompson
Journal:  Nat Rev Cancer       Date:  2019-10-30       Impact factor: 60.716

8.  Pathways to breast cancer recurrence.

Authors:  Aamir Ahmad
Journal:  ISRN Oncol       Date:  2013-02-28

9.  Upregulation of EGFR signaling is correlated with tumor stroma remodeling and tumor recurrence in FGFR1-driven breast cancer.

Authors:  Xue B Holdman; Thomas Welte; Kimal Rajapakshe; Adam Pond; Cristian Coarfa; Qianxing Mo; Shixia Huang; Susan G Hilsenbeck; Dean P Edwards; Xiang Zhang; Jeffrey M Rosen
Journal:  Breast Cancer Res       Date:  2015-11-18       Impact factor: 6.466

10.  Overexpression of COL11A1 by cancer-associated fibroblasts: clinical relevance of a stromal marker in pancreatic cancer.

Authors:  Carmen García-Pravia; José A Galván; Natalia Gutiérrez-Corral; Lorena Solar-García; Eva García-Pérez; Marcos García-Ocaña; Jokin Del Amo-Iribarren; Primitiva Menéndez-Rodríguez; Juan García-García; Juan R de Los Toyos; Laureano Simón-Buela; Luis Barneo
Journal:  PLoS One       Date:  2013-10-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.